ORIC
OricCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
Current thesis
Composite grade C from latest DB weights. Momentum 73.7 / Value 41.1
Posture
Mixed
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta -5.7.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
74
Value
41
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-07-18
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $20.29
Why
Momentum74 · Δ7d -5.7
Value41 · Δ7d -0.1
SentimentN/A · Δ7d -
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Momentum · See technicals
Momentum
74
40% active weight
Current posture
7d trendSoftening
Δ7d
-5.7
Δ21d
+55.8
Value
41
60% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
0.0
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade C. Momentum 73.7 / Value 41.1
Fundamentals (TTM)As of 2026-07-17
Fundamentals (TTM)
As of 2026-07-17
Market Cap
$1.11B
Beta
1.34
Shares Out
103.52M
P/E (TTM) · Derived
-7.3
P/S (TTM)
-
P/FCF (TTM) · Derived
-8.86
Rev YoY
-
EPS YoY
-19.8%
Gross Margin
-
Op Margin
-
Net Debt
-$274.05M
Current Ratio
16.33
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology